HOME PAGE  | 
Covance - solutions made real
POWERFUL ANALYTICS, EXPANDED CAPABILITIES
SCHEDULE YOUR LIVE DEMO TO GET A PERSONAL WALKTHROUGH
Request a live demo and understand how the comprehensive analytical capabilities of the Xcellerate Informatics platform could work for you.
BURLINGTON, N.C. - May 11, 2016 - Laboratory Corporation of America® Holdings (LabCorp®) (NYSE: LH), the world’s leading healthcare diagnostics company, today announced that Covance Drug Development has received the Clinical & Research Excellence (CARE) Award for Best Sponsor-Focused Technological Development for its Xcellerate® Monitoring solution. Xcellerate Monitoring is a first-in-kind global, central monitoring solution that integrates, analyzes and visualizes relevant clinical trial data in near real time to mitigate risk, protect patient safety and drive better and faster clinical trial results, for a single study or across an entire portfolio of trials. 
Xcellerate® Monitoring Excels at Delivering Actionable Information that Mitigates Risk, Protects Patient Safety and Drives Faster Clinical Trial Results

I am interested in:

Covance by Labcorp respects your privacy.
Manage your subscriptions.
© Copyright 2021 Covance by Labcorp Inc. All rights reserved.